Trial Information

Summary: Clinical Research Study for the Treatment of Sun Damaged Skin

Sun damaged skin is a fairly common problem, especially here in Colorado where we are known to have an active outdoor lifestyle and where the sun can be quite intense. We are conducting a study for the treatment of Actinic Keratosis (AK) which is a skin affliction that is nearly always caused by long-term and frequent exposure to the sun. If you have been diagnosed with AK, or think you may have it, you may be eligible to participate in this clinical research study, which is investigating the comparative effectiveness of two FDA approved medications for the treatment of AK.

All study related exams and procedures including physical and lab tests are provided at no cost to you. Study participants will also receive compensation for their time and travel.

Contact:

Horizons Clinical Research Center, LLC
4495 Hale Parkway, Suite 101
Denver, CO 80220
Telephone: 303-399-4067
Fax: 303-399-4159
Email:

Profile Page: Horizons Clinical Research Center, LLC, Denver, CO

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: September 10, 2008 at 2:41:23 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA